학술논문
Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013–2019) of the Population Assessment of Tobacco and Health (PATH) Study
Document Type
article
Author
Paulin, Laura M; Halenar, Michael J; Edwards, Kathryn C; Lauten, Kristin; Stanton, Cassandra A; Taylor, Kristie; Hatsukami, Dorothy; Hyland, Andrew; MacKenzie, Todd; Mahoney, Martin C; Niaura, Ray; Trinidad, Dennis; Blanco, Carlos; Compton, Wilson M; Gardner, Lisa D; Kimmel, Heather L; Lauterstein, Dana; Marshall, Daniela; Sargent, James D
Source
Respiratory Research. 23(1)
Subject
Language
Abstract
BackgroundWe examined the association of non-cigarette tobacco use on chronic obstructive pulmonary disease (COPD) risk in the Population Assessment of Tobacco and Health (PATH) Study.MethodsThere were 13,752 participants ≥ 40 years with Wave 1 (W1) data for prevalence analyses, including 6945 adults without COPD for incidence analyses; W1-5 (2013-2019) data were analyzed. W1 tobacco use was modeled as 12 mutually-exclusive categories of past 30-day (P30D) single and polyuse, with two reference categories (current exclusive cigarette and never tobacco). Prevalence and incidence ratios of self-reported physician-diagnosed COPD were estimated using weighted multivariable Poisson regression.ResultsW1 mean (SE) age was 58.1(0.1) years; mean cigarette pack-years was similar for all categories involving cigarettes and exclusive use of e-cigarettes (all > 20), greater than exclusive cigar users (